The relative economics of screening for colorectal cancer, breast cancer and cervical cancer (Q73304006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

The relative economics of screening for colorectal cancer, breast cancer and cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

cervix uterine cancer

1 reference

Gyrd-Hansen D

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Oncology Hematology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

133-144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

Randomised study of screening for colorectal cancer with faecal-occult-blood test

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Colorectal cancer screening: efficiency and effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

A cost-effectiveness analysis of cervical cancer screening: health policy implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Analysis of screening data: colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Simplified models of screening for chronic disease: estimation procedures from mass screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Fecal occult blood tests. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Natural history of untreated colonic polyps.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

The Funen Adenoma Follow-up Study. Incidence and death from colorectal carcinoma in an adenoma surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

The cost-effectiveness of breast cancer screening.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

The costs of treating breast cancer in Australia and the implications for breast cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Preventive Pap-smears: balancing costs, risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

A computer simulation model for the practical planning of cervical cancer screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

The MISCAN simulation program for the evaluation of screening for disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Model building on the basis of Dutch cervical cancer screening data

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Optimization of cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Colorectal cancer screening and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

Faecal occult blood screening for colorectal cancer: is it cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900022-0

7 January 2021

10.1016/S1040-8428(99)00022-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10612013%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference